Literature DB >> 1852536

Accumulation of odd-numbered long-chain fatty acids in fetuses and neonates with inherited disorders of propionate metabolism.

U Wendel1, R Baumgartner, S B van der Meer, L J Spaapen.   

Abstract

Fetuses affected with propionic acidemia incorporate great amounts of odd-numbered long-chain fatty acids (OLCFA) into their body lipids. This is due to abundant supply with precursor amino acids of propionyl-CoA throughout pregnancy. After birth, the lower provision of precursor amino acids during dietary treatment compared with fetal life results in a decline of propionyl-CoA production and therefore OLCFA synthesis. However, the observed decrease of OLCFA may also partly reflect the recovery from acute ketoacidotic episodes that the patients experienced soon after birth as long as they were undiagnosed. In a patient with vitamin B12-responsive methylmalonic aciduria treated prenatally with large doses of vitamin B12 given to the mother, the cord plasma lipids contained normal amounts of OLCFA. This indicates that prenatal therapy led to an increased flux of propionyl-CoA through the defective methylmalonyl-CoA mutase step. Thus, in addition to the quantification of a decline in methylmalonic acid in maternal urine, OLCFA in cord blood lipids might be a further parameter for evaluating prenatal treatment in patients with vitamin B12-responsive methylmalonic aciduria.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852536     DOI: 10.1203/00006450-199104000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

Review 1.  The management and outcome of propionic and methylmalonic acidaemia.

Authors:  J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Evaluation of prenatal treatment in newborns with cobalamin-responsive methylmalonic acidaemia.

Authors:  R Zass; D Leupold; M A Fernandez; U Wendel
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.

Authors:  Sabrina Malvagia; Christopher A Haynes; Laura Grisotto; Daniela Ombrone; Silvia Funghini; Elisa Moretti; Kathleen S McGreevy; Annibale Biggeri; Renzo Guerrini; Raquel Yahyaoui; Uttam Garg; Mary Seeterlin; Donald Chace; Victor R De Jesus; Giancarlo la Marca
Journal:  Clin Chim Acta       Date:  2015-09-11       Impact factor: 3.786

4.  Contribution of odd-numbered fatty acid oxidation to propionate production in neonates with methylmalonic and propionic acidaemias.

Authors:  U Wendel; R Zass; D Leupold
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

5.  Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect.

Authors:  Patrick Forny; Anke Schumann; Merima Mustedanagic; Déborah Mathis; Marie-Angela Wulf; Nadine Nägele; Claus-Dieter Langhans; Assem Zhakupova; Joerg Heeren; Ludger Scheja; Ralph Fingerhut; Heidi L Peters; Thorsten Hornemann; Beat Thony; Stefan Kölker; Patricie Burda; D Sean Froese; Olivier Devuyst; Matthias R Baumgartner
Journal:  J Biol Chem       Date:  2016-08-12       Impact factor: 5.157

6.  Liver transplantation in two cases of propionic acidaemia.

Authors:  J S Schlenzig; F Poggi-Travert; J Laurent; D Rabier; D Jan; U Wendel; A C Sewell; Y Revillon; P Kamoun; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Long-term follow-up with filter paper samples in patients with propionic acidemia.

Authors:  Sinziana Stanescu; Amaya Belanger-Quintana; Borja Manuel Fernández-Felix; Celia Pérez-Cerdá; Begoña Merinero; Pedro Ruiz-Sala; Francisco Arrieta; Mercedes Martínez-Pardo
Journal:  JIMD Rep       Date:  2020-09-27

8.  Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle.

Authors:  Randy J Chandler; Jennifer Sloan; Hong Fu; Matthew Tsai; Sally Stabler; Robert Allen; Klaus H Kaestner; Haig H Kazazian; Charles P Venditti
Journal:  BMC Med Genet       Date:  2007-10-15       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.